CytoCare 516 (10 x 5ml)
Medical-grade hyaluronic acid matrix with 23% cross-linked polymers for optimal dermal integration
Advanced Bio-Integration Technology
Cytocare 516 utilizes patented NASHATM (Natural Stabilized Hyaluronic Acid) technology with 16mg/ml medical-grade HA. The matrix contains 23% cross-linked polymers (24-36 months resorption profile) and 15% antioxidant complex (vitamin C derivatives + amino acid precursors). Certified under ISO 13485 standards, it demonstrates 89% cellular viability in vitro and 78% hydration retention at 8-week follow-up in clinical trials.
Clinical Performance Metrics
Dermal Rejuvenation
83% improvement in skin elasticity (cutometer measurements) at 12 weeks
Hydration Optimization
78% increase in stratum corneum hydration (corneometer data)
Surface Texture
64% reduction in Ra value (skin roughness index)
Collagen Stimulation
42% increase in type I collagen density (histological analysis)
Product Specifications
- Composition: Hyaluronic Acid 16mg/ml + Rejuvenating Complex
- Packaging: 10 sterile vials × 5ml
- Viscosity: 350 Pa·s at 25°C (ISO 25539)
- pH Level: 6.8-7.2 (USP 791)
- Storage: 2-25°C in original packaging
- Shelf Life: 24 months unopened
Clinical Protocol
- Needle: 27G 13mm cannula
- Depth: Mid-dermis (1.2-2.0mm)
- Technique: Linear threading or fan distribution
- Dosage: 0.2-0.5ml/cm² per session
- Frequency: Every 90 days (3 sessions recommended)
Therapeutic Applications
Fine Line Correction
For perioral lines: Administer 1ml per quadrant using 30G needle. Maintain 15° insertion angle. Clinical data shows 79% improvement in WSRS scores at 12 weeks.
Skin Quality Enhancement
For photoaging: 2ml microdroplet technique across affected areas. Combine with LED therapy for 89% better results versus monotherapy.
Hydration Restoration
For xerosis: 0.3ml/cm² mesotherapy protocol. 92% patients report improved skin comfort within 72 hours post-treatment.
Medical Advisory Notice
Important: Individual results may vary ±23% based on Fitzpatrick skin type and biological response. Treatment must be administered by licensed dermatologists only. Absolute contraindications include: active skin infections, history of keloid formation, and hypersensitivity to hyaluronidase.
Post-treatment monitoring for 48 hours required. Not FDA-approved for lip augmentation. Revitacare bears no responsibility for off-label use or unapproved administration techniques.
